BRTX vs HRL · rev $359.7K vs P/E 29, rev $8.96B
BioRestorative Therapies Inc (BRTX) versus Hormel Foods Corporation (HRL) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
BRTX currently screens at market cap $10.2M. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Not investment advice. Open the BRTX and HRL stock pages for the full models.
Not investment advice.